Maria Sunzel - Teva Pharmaceuticals

Maria SUNZEL, PhD

Dose-Normalized Pharmacokinetic Parameters for the Active HTBZ

Mark Forrest Gordon's research works Teva Pharmaceutical Industries Ltd., Petah Tikva (TEVA) and other places

Pippa Loupe's research works Teva Pharmaceutical Industries Ltd., Petah Tikva (TEVA) and other places

ProductCreationTemplate 2020-12-03 1

PDF) Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis

Conrad Cowan - Director Project Leadership - Teva Pharmaceuticals

Maria Sunzel - Teva Pharmaceuticals

PDF) The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers

Edward Hellriegel - Teva Pharmaceuticals

PDF) Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study